Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer - Zhang, Mengjun; Liu, Yunduo; Liu, Yuan; Hou, Siyu; Li, Hao; Ma, Ying; Wang, Can; Chen, Xiuwei (Frontiers in Genetics, 2022)